Published

Psychedelic therapists, pharma collaborate on clinical trial

A New York-based organization, considered a global leader in professional education and training for psychedelic therapy research, is collaborating with a biotechnology company to develop an FDA-approved botanical psilocybin pharmaceutical candidate to support an upcoming randomized clinical trial.

Open source BibTeX RIS

Bibliographic context

Journal: Mental Health Weekly
Date: 2024-04-12
Source: OpenAlex
DOI: 10.1002/mhw.34009
PubMed: Unavailable

Authors

Valerie A. Canady

Watch author

Topics and keywords

psilocybin Clinical Trial Randomized Controlled Trial Randomized Controlled Trial Psilocybin Clinical trial Alternative medicine Medicine Randomized controlled trial Medical education Psychology Psychiatry Surgery Hallucinogen Pathology Psychedelics and Drug Studies

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Psychedelic therapists, pharma collaborate on clinical trial2024-04-12

Related papers

PSILOCYBIN AS AN ADJUNCTIVE TREATMENT FOR DEPRESSION AND PSYCHOLOGICAL DISTRESS IN ONCOLOGY: CURRENT EVIDENCE AND CLINICAL IMPLICATIONSInternational Journal of Innovative Technologies in Social Science · 2026-03-18 Psilocybin shows rapid relief for depression symptomsMental Health Weekly · 2026-05-28 Blinding integrity in psychedelic research: Evidence from a comparative randomized controlled trial of psilocybin, MDMA, and methylphenidate in healthy volunteers.Open Access CRIS of the University of Bern · 2026-05-27 Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression (EPIsoDE): 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialPsychotherapy and Psychosomatics · 2026-05-26 Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic PotentialDigital Showcase Research, Scholarship, & Creative Works (University of Lynchburg) · 2026-05-21 Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal IdeationThe Journal of Clinical Psychiatry · 2026-05-11 Psilocybin in the Treatment of Cocaine Use DisorderJAMA Network Open · 2026-05-06 A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depressionNature Mental Health · 2026-04-05